FDA Investigator Anya Dlockett Evans
Anya Dlockett Evans has conducted inspections on 202 sites in 4 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
202
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Canada,
France
FDA Investigators that have inspected at least one site in common with Anya Dlockett Evans:
Abby Lmozeke Baker,
Akbar J Zaidi,
Albert F Peacock, PhD,
Althea A Williams,
Amanda J White,
Andrea A Branche,
Angela Mock,
Angela Shepas,
Annette Melendez,
Arie R Dyk,
Ashley N Williams,
Audrey J Yarbrough,
Barbara G Peoples,
Bhanu M Kannan,
Bing Lin,
Blondell W Johnson,
Bobbi J Miller,
Bonnie L Menzel,
Brenda G Stewart Munoz,
Brian Sanders,
Brook Shea,
Bryce A May,
Carol F Robinson,
Cassandra L Abellard,
Cathleen A Castellaw,
Charles D Brown,
Charles L Larson,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher K Gibbs,
Connie L Hannon Rabel,
Corrine M Carter,
Cynthia A Harris, MD, RN,
Dana M Lewis,
Daniel S Fam,
Danielle Lyke,
Darla J Christopher,
Debra Lboyd Seale,
Decarlos A Gomez,
Denise Connelly,
Denise L Burosh,
Deniza Karacic,
Dennis R Hudson,
Diana L Ayala,
Diane Hall,
Dr. Jason R Caballero,
Elisa M Fleming,
Elmina E Akwo,
Elmina E Mboh,
Emily S Mcgann,
Enspect User,
Eric S Myskowski,
Erma Zaimova,
Ernest Serna, III,
Everard A Irish,
Fernando C Martinez,
Frans E Mercado,
Gloria A Milster,
Grant L Davis,
Habacuc V Barrera,
Hala L Selby,
Hamed Ghoda,
Hoimay Chan,
Iris C Macinnes,
J Elkins,
James M Kewley,
Janet B Abt,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer A Kemp,
Jennifer D Young,
Jennifer Hua,
Jocelyn C Turner,
Jodi M Gatica,
Joel D Martinez,
Jogy George,
Johann M Fitch,
Judy Ellen Ciaraldi,
Karlton T Watson,
Kathleen B Swat,
Kelly D Sheppard,
Kelly J Pegg,
Kenitra D Hewitt,
Kenneth L Smalls,
Kimberly Lewandowski Walker,
Kip J Hanks,
L Grant,
Latorie S Jones,
Laura E Garcia,
Lauren E Skokan,
Lauren M Lilly, PhD,
Lawrence C Coleman,
Leighton Kn Gai,
Lesley Maep Lutao,
Lillie M Young,
Lisa A Doyle,
Lisa M Puttonen,
Lisa R Jennings,
Lisa R Whitt,
Lloyd D Payne,
Lori A Gioia,
Lorie S Hannappel,
Lourdes R Genera,
Lynnette I Riggio,
Maira P Brading,
Marc A Jackson, Jr,
Marc R Dickens,
Mariana F Baxter,
Mark W Babbitt,
Mary E Baker Brown,
Matthew J Gretkierewicz,
Melissa D Kalik,
Merelynn Rhoten,
Michael I Gorman,
Michelle Paxon,
Monique S Frazier,
Nimmy Mathews,
Patricia M Jacobs,
Patrick D Stone, MS,
Pauline N Logan,
Perla M Castillo,
Philip M Steele, PhD,
Phillip D Waldron,
Rebecca Co Bryan,
Rebecca L Stephany,
Rhonda L Dash,
Richard T Riggie,
Robert M Tillman,
Ronda Rloyd Jones,
Rose Ashley,
Rosia E Nesbitt,
Roy Baby,
Ruth E Medcalf,
Saleem A Akhtar,
Scott B Laufenberg,
Scott R Nichols, PhD,
Scott T Ballard,
Shannon A Lowe,
Sharyn K Miller,
Shusheen A Alexander,
Sunitha K Rajaram, PhD,
Tamera H Hunt,
Tara A Gray,
Terrance L Thomas,
Toby Vern H Hill,
Tracy J Washington,
Travis M Beard,
Tricia S Martinez,
Trina K Vick,
William F Lagud, Jr,
William P Tonkins,
Yaw O Osei,
Young M Yoon,
Zerita White
Anya Dlockett Evans's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2013 | EIR | Stillmeadow Incorporated - EIR, 2013-06-04 |
April, 2009 | FDA 483 | Abbott Medical - Form 483, 2009-04-06 |
December, 2021 | FDA 483 | Koriand'r Williams, M.D. - Form 483, 2022-01-31 |
December, 2021 | EIR | Koriand'r Williams, M.D. - EIR, 2021-12-22 |
November, 2021 | FDA 483 | John Heymach, M.D - Form 483, 2021-11-05 |
April, 2009 | FDA 483 Response | Abbott Medical - Form 483R, 2009-04-13 |
May, 2018 | FDA 483 | Elkhalili, Abdelnaser MD - Form 483, 2018-05-14 |
June, 2013 | FDA 483 | Stillmeadow Incorporated - Form 483, 2013-06-04 |
April, 2009 | EIR | Abbott Medical - EIR, 2009-04-06 |
August, 2019 | FDA 483 | Stefan W. Kreuzer, MD - Form 483, 2019-08-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more